Monia Marchetti

8.5k total citations
113 papers, 3.3k citations indexed

About

Monia Marchetti is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Monia Marchetti has authored 113 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 44 papers in Genetics and 20 papers in Oncology. Recurrent topics in Monia Marchetti's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (21 papers), Lymphoma Diagnosis and Treatment (17 papers) and Hemoglobinopathies and Related Disorders (14 papers). Monia Marchetti is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (21 papers), Lymphoma Diagnosis and Treatment (17 papers) and Hemoglobinopathies and Related Disorders (14 papers). Monia Marchetti collaborates with scholars based in Italy, United States and United Kingdom. Monia Marchetti's co-authors include Giovanni Barosi, S Tura, Nicola Lucio Liberato, Alberto Grossi, Tiziano Barbui, Gianluca Viarengo, Vittorio Rosti, Silvana Quaglini, Alessandro Pecci and Pier Luigi Zinzani and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The American Journal of Medicine.

In The Last Decade

Monia Marchetti

106 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monia Marchetti Italy 33 1.7k 1.6k 774 505 442 113 3.3k
J Brière France 28 1.2k 0.7× 1.0k 0.6× 596 0.8× 255 0.5× 358 0.8× 138 3.0k
Alan Lichtin United States 27 1.9k 1.2× 1.0k 0.6× 487 0.6× 570 1.1× 278 0.6× 101 3.8k
Massimo Breccia Italy 38 4.1k 2.5× 2.6k 1.6× 1.7k 2.2× 942 1.9× 1.1k 2.5× 403 5.6k
Smith Giri United States 29 1.2k 0.7× 488 0.3× 725 0.9× 991 2.0× 159 0.4× 262 3.2k
Matt Kalaycio United States 31 3.3k 2.0× 1.5k 0.9× 1.4k 1.7× 1.2k 2.4× 436 1.0× 291 5.1k
Wolfgang Miesbach Germany 27 1.7k 1.0× 371 0.2× 567 0.7× 511 1.0× 297 0.7× 192 3.2k
Amer M. Zeidan United States 40 3.7k 2.2× 1.4k 0.9× 2.0k 2.6× 1.3k 2.6× 184 0.4× 407 5.6k
Arturo Pereira Spain 37 3.3k 2.0× 3.5k 2.2× 1.7k 2.2× 217 0.4× 1.2k 2.6× 154 5.2k
Jan‐Stephan Sanders Netherlands 34 1.8k 1.0× 802 0.5× 451 0.6× 848 1.7× 430 1.0× 168 4.2k
Marco Vignetti Italy 36 2.8k 1.6× 775 0.5× 1.2k 1.5× 1.0k 2.1× 216 0.5× 156 4.2k

Countries citing papers authored by Monia Marchetti

Since Specialization
Citations

This map shows the geographic impact of Monia Marchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monia Marchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monia Marchetti more than expected).

Fields of papers citing papers by Monia Marchetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monia Marchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monia Marchetti. The network helps show where Monia Marchetti may publish in the future.

Co-authorship network of co-authors of Monia Marchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Monia Marchetti. A scholar is included among the top collaborators of Monia Marchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monia Marchetti. Monia Marchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marchetti, Monia, Paolo Corradini, Luca Arcaini, et al.. (2025). A SWOT‐Consensus for CAR‐T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection. Hematological Oncology. 43(5). e70125–e70125.
2.
Tripodi, Armando, Walter Ageno, Luca Barcella, et al.. (2025). Facts and Misfacts on D ‐Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis ( SISET ). American Journal of Hematology. 101(1). 97–109.
3.
Bellosillo, Beatríz, Michael Doubek, Ciprian Tomuleasa, et al.. (2024). JAK2 mutations in polycythemia vera: from molecular origins to inflammatory pathways and clinical implications. memo - Magazine of European Medical Oncology. 17(S4). 79–93.
4.
5.
Russo, Rodolfo, Tommaso Casini, Letizia Lombardini, et al.. (2023). Nephrological Complications in Hemoglobinopathies: SITE Good Practice. Journal of Clinical Medicine. 12(23). 7476–7476. 1 indexed citations
6.
Casale, Maddalena, Marina Baldini, Patrizia Del Monte, et al.. (2022). Le principali complicanze endocrinologiche nelle emoglobinopatie: buone pratiche cliniche della Società Italiana Talassemie ed Emoglobinopatie (SITE)*. Recenti Progressi in Medicina. 113(9). 495–554. 1 indexed citations
7.
Baronciani, D, Maddalena Casale, Lucia De Franceschi, et al.. (2021). Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm. HemaSphere. 5(5). e555–e555. 6 indexed citations
8.
Rognoni, Carla, Monia Marchetti, Silvana Quaglini, & Nicola Lucio Liberato. (2014). Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis. Journal of Thrombosis and Thrombolysis. 39(2). 149–154. 32 indexed citations
9.
10.
Olivieri, Jacopo, Luca Pierelli, Martino Introna, et al.. (2013). Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey. Cytotherapy. 16(1). 101–110. 3 indexed citations
11.
Mauro, Francesca Romana, Giuseppe Bandini, Giovanni Barosi, et al.. (2011). SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia. Leukemia Research. 36(4). 459–466. 6 indexed citations
12.
Marchetti, Monia, et al.. (2011). Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment. Infection. 39(4). 375–378. 12 indexed citations
13.
Angelucci, Emanuele, Giovanni Barosi, Monia Marchetti, & S Tura. (2009). Italian Society of Hematology guidelines for thalassemia and non-invasive iron measurements: author reply. Haematologica. 94(2). 295–296. 1 indexed citations
14.
Tosi, Patrizia, Giovanni Barosi, Carlo Lazzaro, et al.. (2008). Consensus conference on the management of tumor lysis syndrome. Haematologica. 93(12). 1877–1885. 89 indexed citations
15.
Liberato, Nicola Lucio, Monia Marchetti, & Giovanni Barosi. (2007). Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer. Journal of Clinical Oncology. 25(6). 625–633. 108 indexed citations
16.
Marchetti, Monia & Giorgio Lorenzo Colombo. (2005). Cost-effectiveness of universal pneumococcal vaccination for infants in Italy. Vaccine. 23(37). 4565–4576. 18 indexed citations
17.
Barosi, Giovanni, Mario Boccadoro, Michèle Cavo, et al.. (2004). Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO).. PubMed. 89(6). 717–41. 57 indexed citations
18.
Alessandrino, Emilio Paolo, Sergio Amadori, Giovanni Barosi, et al.. (2002). Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.. PubMed. 87(12). 1286–306. 141 indexed citations
19.
Marchetti, Monia, Anna Sofia Delussu, & Angelo Rodio. (2001). La medicina dello sport... per sport. Medicina dello Sport. 54(2). 145–153. 1 indexed citations
20.
Marchetti, Monia & Giovanni Barosi. (2000). Cost‐effectiveness of epoetin and autologous blood donationin reducing allogeneic blood transfusions incoronary artery bypass graft surgery. Transfusion. 40(6). 673–681. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Brière Breakdown of academic impact, for papers by Alan Lichtin Breakdown of academic impact, for papers by Massimo Breccia Breakdown of academic impact, for papers by Smith Giri Breakdown of academic impact, for papers by Matt Kalaycio Breakdown of academic impact, for papers by Wolfgang Miesbach Breakdown of academic impact, for papers by Amer M. Zeidan Breakdown of academic impact, for papers by Arturo Pereira Breakdown of academic impact, for papers by Jan‐Stephan Sanders Breakdown of academic impact, for papers by Marco Vignetti
Rankless by CCL
2026